BENITO AGUILAR STARTED WORKING IN THE 503B INDUSTRY
In 2018, Benito Aguilar started working in the 503B industry when he joined a leading provider in Texas. However, his journey into the industry began when he immigrated to the United States in 1979 and settled in Chicago. Two years later, he moved to Houston, where he faced a family tragedy when his father passed away, leaving his mother to raise four children on her own. Despite the challenges he faced, Benito remained dedicated to his education, earning a Bachelor of Science degree in Chemistry and a Bachelor of Science degree in Biology. Immediately after graduation, he started his career in the industry working as a QA for a vitamin manufacturer. During this time, he also managed the micro lab for the same company, gaining valuable experience in various aspects of the industry. Throughout his career, Benito has held several positions in pharmaceutical industry and worked as a consultant. These roles have given him a broad perspective and allowed him to gain valuable experience from the beginning to the end of the processes in the pharmaceutical industry, as well as in facility management.BIRTH OF ATILAR PHARMA
Frustrated by the lack of quality and cleanliness he witnessed in the industry, Benito Aguilar decided to take matters into his own hands. He believed that he could make a difference by starting his own 503B business that would not only provide high-quality compounded medications but also raise the standard for the entire industry.
As an industry insider, he knew that standardization was a major issue in the industry, and he was determined to change that. He spent three years courting investors and building a team of professionals who shared his vision of creating an industry-referent business that would be known for its commitment to safety, quality, and standardization. The result was the birth of Atilar Pharma, a 503B company that is dedicated to providing safe, effective, and reliable compounded medications to patients and healthcare providers.
CLEAN ROOM INSTALLED AND CERTIFIED
In 2023, Atilar Pharma is set to achieve significant milestones. After months of hard work and dedication, the company is poised to begin sales of their high-quality products, making a difference in the lives of patients and healthcare providers, and earning a reputation for excellence in the industry.
In addition to this exciting development, the company is preparing to install a brand new, state-of-the-art cleanroom facility. This installation will allow Atilar Pharma to expand their manufacturing capabilities and product offerings later this year.
As the team prepares for the upcoming launch and installation, they are confident that these actions will be a true testament to the hard work and dedication of the team. These milestones will be a sign of the great things to come for Atilar Pharma, as they know that with this new facility in place, they will be better positioned than ever to meet the needs of their customers and make a positive impact on the healthcare industry.
OUR 503 B FACILITY
Our state-of-the-art facility is equipped with the latest technology and staffed by a team of highly trained and experienced professionals. We understand the unique needs and challenges facing patients and healthcare providers, and we are dedicated to providing safe, effective, and reliable solutions to meet these needs.
One of the key features of our 503B facility is our partnership with ESC Environmental Systems Corporation, a leading provider of environmental control solutions. Together, we have developed a customized cleanroom system that meets the highest industry standards for quality and safety. This system utilizes advanced air filtration and purification technology, as well as automated temperature and humidity control, to create a controlled environment that is essential for the compounding of safe and effective medications.
REDEFINING THE 503B INDUSTRY
At Atilar Pharma, we are committed to setting a new standard for the 503B industry through a focus on innovation, collaboration, and patient-centricity. We believe that by prioritizing these values, we can redefine and improve current practices to better meet the needs of patients and healthcare providers.
Innovation is a key driver of our efforts to redefine the 503B industry. We understand that the traditional approach to compounding may not meet the unique needs of patients and healthcare providers today. Therefore, we are continually exploring new ways to enhance accuracy, quality, and safety in compounding by leveraging advanced technologies, best practices, and expertise.
We engage in open and transparent communication with our partners to better understand their needs, concerns, and feedback, which allows us to continuously improve our services and develop innovative solutions.
10% OFF
Submit your Letter of Intent (LOI)
between December 1, 2023 and April 30, 2024,
and receive 10% off on all orders
for one year
5% OFF
Submit your Letter of Intent (LOI)
between May 1 and May 31, 2024,
and receive 5% off on all orders
for one year
Secure your discount
by pre-ordering today
At Atilar Pharma, we strive to stay at the forefront of the 503B industry by dedicating significant resources to continuously improve our manufacturing processes. Our team of experts is constantly seeking innovative approaches to compounding that result in safe and effective medications that meet the unique needs of patients and healthcare providers.
Our cutting-edge facility is equipped with the latest technology to support our research and development efforts. We prioritize precision and accuracy at every step of the manufacturing process, from sourcing high-quality ingredients to thorough testing and quality control. Our team is passionate about advancing the science of compounding, and we work tirelessly to remain up-to-date with the latest research, trends, and best practices in the industry.
Our commitment to research and development is driven by our unwavering dedication to improving patient outcomes. With this approach, we can help healthcare providers address unmet needs and provide patients with better treatment options.
Our culture is centered on excellence, innovation, and collaboration. We are committed to fostering an environment that empowers our team members to do their best work, while also encouraging creativity, curiosity, and growth. We believe that a positive, supportive culture is essential to our success and the satisfaction of our customers, and we prioritize this through everything we do.
Atilar Pharma is built on a foundation of respect, transparency, and communication. We believe in creating an environment where all team members feel valued, heard, and understood. We foster a spirit of collaboration and teamwork, which allows us to bring together diverse perspectives and ideas to find the best solutions. We also prioritize ongoing learning and development, offering opportunities for professional growth and supporting our team members in their pursuit of excellence. By nurturing a culture that values innovation, teamwork, and personal development, we believe that we can continue to push the boundaries of what is possible in the 503B industry, while also creating a positive and fulfilling workplace for our team members.
Our culture is not only about creating a great workplace for our team members but also about serving the needs of our customers. We prioritize a customer-centric approach, which means that we listen carefully to our customers’ needs and work tirelessly to exceed their expectations.
At Atilar Pharma, quality assurance is a top priority. Our comprehensive quality management system ensures that all aspects of the manufacturing process are closely monitored, from the sourcing of raw materials to the final inspection and testing of the compounded medication. We adhere to strict guidelines and procedures for every step of the process to ensure that our customers receive high-quality compounded medications that are safe, effective, and reliable.
We regularly evaluate our quality assurance procedures to identify areas for improvement and ensure that our products and services consistently meet or exceed the highest industry standards. Our team of experts stays up-to-date with the latest industry trends, regulations, and best practices to maintain our commitment to quality and compliance. At Atilar Pharma, quality assurance is a core component of our mission and a reflection of our unwavering dedication to providing safe and effective compounded medications that meet the unique needs of patients and healthcare providers.